Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats

Abstract Abnormalities in the metabolism of essential fatty acids and the results of increased oxidative stress have been implicated in cardiovascular disorders observed in diabetes mellitus. This study, therefore, aimed to investigate the effects of cod liver oil (CLO, Lysi Ltd, Iceland), which com...

Full description

Bibliographic Details
Published in:Journal of Pharmacy and Pharmacology
Main Authors: Ceylan-Isık, Aslı, Hünkar, Tuǧba, Aşan, Esin, Kaymaz, Fugen, Arı, Nuray, Söylemezoǧlu, Tülin, Renda, Nurten, Soncul, Halim, Bali, Musa, Karasu, Çimen
Format: Article in Journal/Newspaper
Language:English
Published: Oxford University Press (OUP) 2007
Subjects:
Online Access:http://dx.doi.org/10.1211/jpp.59.12.0004
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1211%2Fjpp.59.12.0004
http://academic.oup.com/jpp/article-pdf/59/12/1629/36738625/jpp.59.12.0004.pdf
id croxfordunivpr:10.1211/jpp.59.12.0004
record_format openpolar
spelling croxfordunivpr:10.1211/jpp.59.12.0004 2023-12-31T10:08:24+01:00 Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats Ceylan-Isık, Aslı Hünkar, Tuǧba Aşan, Esin Kaymaz, Fugen Arı, Nuray Söylemezoǧlu, Tülin Renda, Nurten Soncul, Halim Bali, Musa Karasu, Çimen 2007 http://dx.doi.org/10.1211/jpp.59.12.0004 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1211%2Fjpp.59.12.0004 http://academic.oup.com/jpp/article-pdf/59/12/1629/36738625/jpp.59.12.0004.pdf en eng Oxford University Press (OUP) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model Journal of Pharmacy and Pharmacology volume 59, issue 12, page 1629-1641 ISSN 0022-3573 2042-7158 Pharmaceutical Science Pharmacology journal-article 2007 croxfordunivpr https://doi.org/10.1211/jpp.59.12.0004 2023-12-06T08:37:14Z Abstract Abnormalities in the metabolism of essential fatty acids and the results of increased oxidative stress have been implicated in cardiovascular disorders observed in diabetes mellitus. This study, therefore, aimed to investigate the effects of cod liver oil (CLO, Lysi Ltd, Iceland), which comprises mainly an antioxidant vitamin A, n:3 polyunsaturated fatty acids (n:3 PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular abnormalities in streptozotocin (STZ)-diabetic rats. Two days after single STZ (55 mg kg−1, i.p.) or vehicle injection, diabetes was verified by increased blood glucose, and non-diabetic and diabetic rats were left untreated or treated with CLO (0.5 mL kg−1 daily, by intragastric probing) for 12 weeks. Plasma glucose, triacylglycerol and cholesterol concentrations were significantly elevated in 12-week untreated-diabetic rats; CLO provided better weight gain, entirely prevented the plasma lipid abnormalities, but partially controlled the glycaemia in diabetic rats. In isolated aorta rings, diabetes resulted in increased phenylephrine-induced vasoconstriction and isoprenaline-induced vasorelaxation, impaired endothelium-dependent vasodilatation and unchanged responsiveness to sodium nitroprusside. CLO treatment completely prevented endothelial deficiency, partly corrected the phenylephrine-induced vasoconstriction and did not affect the responses to isoprenaline and sodium nitroprusside in diabetic aorta. Diabetes also produced a marked decrease in the rate of spontaneously beating right atria and a significant increase in basal contractile force of left ventricular papillary muscle. The responsiveness of right atria to the positive chronotropic effect of isoprenaline was significantly decreased in diabetic rats, and was increased in CLO-treated diabetic rats. The positive chronotropic effect of noradrenaline was markedly increased in diabetic atria, but prevented by CLO treatment. Diabetes also resulted in an increased positive inotropic response of ... Article in Journal/Newspaper Iceland Oxford University Press (via Crossref) Journal of Pharmacy and Pharmacology 59 12 1629 1641
institution Open Polar
collection Oxford University Press (via Crossref)
op_collection_id croxfordunivpr
language English
topic Pharmaceutical Science
Pharmacology
spellingShingle Pharmaceutical Science
Pharmacology
Ceylan-Isık, Aslı
Hünkar, Tuǧba
Aşan, Esin
Kaymaz, Fugen
Arı, Nuray
Söylemezoǧlu, Tülin
Renda, Nurten
Soncul, Halim
Bali, Musa
Karasu, Çimen
Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
topic_facet Pharmaceutical Science
Pharmacology
description Abstract Abnormalities in the metabolism of essential fatty acids and the results of increased oxidative stress have been implicated in cardiovascular disorders observed in diabetes mellitus. This study, therefore, aimed to investigate the effects of cod liver oil (CLO, Lysi Ltd, Iceland), which comprises mainly an antioxidant vitamin A, n:3 polyunsaturated fatty acids (n:3 PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on cardiovascular abnormalities in streptozotocin (STZ)-diabetic rats. Two days after single STZ (55 mg kg−1, i.p.) or vehicle injection, diabetes was verified by increased blood glucose, and non-diabetic and diabetic rats were left untreated or treated with CLO (0.5 mL kg−1 daily, by intragastric probing) for 12 weeks. Plasma glucose, triacylglycerol and cholesterol concentrations were significantly elevated in 12-week untreated-diabetic rats; CLO provided better weight gain, entirely prevented the plasma lipid abnormalities, but partially controlled the glycaemia in diabetic rats. In isolated aorta rings, diabetes resulted in increased phenylephrine-induced vasoconstriction and isoprenaline-induced vasorelaxation, impaired endothelium-dependent vasodilatation and unchanged responsiveness to sodium nitroprusside. CLO treatment completely prevented endothelial deficiency, partly corrected the phenylephrine-induced vasoconstriction and did not affect the responses to isoprenaline and sodium nitroprusside in diabetic aorta. Diabetes also produced a marked decrease in the rate of spontaneously beating right atria and a significant increase in basal contractile force of left ventricular papillary muscle. The responsiveness of right atria to the positive chronotropic effect of isoprenaline was significantly decreased in diabetic rats, and was increased in CLO-treated diabetic rats. The positive chronotropic effect of noradrenaline was markedly increased in diabetic atria, but prevented by CLO treatment. Diabetes also resulted in an increased positive inotropic response of ...
format Article in Journal/Newspaper
author Ceylan-Isık, Aslı
Hünkar, Tuǧba
Aşan, Esin
Kaymaz, Fugen
Arı, Nuray
Söylemezoǧlu, Tülin
Renda, Nurten
Soncul, Halim
Bali, Musa
Karasu, Çimen
author_facet Ceylan-Isık, Aslı
Hünkar, Tuǧba
Aşan, Esin
Kaymaz, Fugen
Arı, Nuray
Söylemezoǧlu, Tülin
Renda, Nurten
Soncul, Halim
Bali, Musa
Karasu, Çimen
author_sort Ceylan-Isık, Aslı
title Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
title_short Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
title_full Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
title_fullStr Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
title_full_unstemmed Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
title_sort cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats
publisher Oxford University Press (OUP)
publishDate 2007
url http://dx.doi.org/10.1211/jpp.59.12.0004
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1211%2Fjpp.59.12.0004
http://academic.oup.com/jpp/article-pdf/59/12/1629/36738625/jpp.59.12.0004.pdf
genre Iceland
genre_facet Iceland
op_source Journal of Pharmacy and Pharmacology
volume 59, issue 12, page 1629-1641
ISSN 0022-3573 2042-7158
op_rights https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
op_doi https://doi.org/10.1211/jpp.59.12.0004
container_title Journal of Pharmacy and Pharmacology
container_volume 59
container_issue 12
container_start_page 1629
op_container_end_page 1641
_version_ 1786841108192428032